AI assistant
DEXCOM INC — Director's Dealing 2023
Jan 21, 2023
30198_dirs_2023-01-20_8b0a2a5c-5a0d-45aa-978e-d1d2a09b3e92.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2023-01-18
Reporting Person: SAYER KEVIN R (Director, President CEO and Chairman of)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-03 | Common Stock | G | 10000 | $0.0 | Disposed | 381532 | Direct |
| 2023-01-18 | Common Stock | A | 90720 | $0.0 | Acquired | 472252 | Direct |
Footnotes
F1: The transaction represents a gift by the Reporting Person of 10,000 shares to a charitable donor advised fund.
F2: Included in this number are 134,792 unvested restricted stock units, 65,004 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 35,852 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 33,936 of which were granted on March 8, 2020 and shall vest through March 8, 2023.
F3: Represents performance stock units ("PSUs") granted to the reporting person on March 8, 2020 that vested on January 18, 2023, with the applicable performance achieved.